Literature DB >> 3033288

Subtyping of European foot-and-mouth disease virus strains by nucleotide sequence determination.

E Beck, K Strohmaier.   

Abstract

The VP1-coding regions of foot-and-mouth disease virus strains from 18 recent European outbreaks and of 9 strains isolated more than 20 years ago and used in part as vaccines were determined by direct cDNA sequencing. Comparison of the sequences revealed that most of the isolated outbreak viruses are closely related to the vaccine strains used. Isolates from the Italian epizootic of 1984 to 1985 correspond, for example, to the vaccine strain A5 Parma 62; the outbreak in 1984 in Bernbeuren, Federal Republic of Germany, was induced by A5 Allier 60; outbreaks in 1982 in Funen, Denmark, and in Murchin, German Democratic Republic, were caused by O1 Lausanne 65. Viruses isolated during the 1983 Iberian epizootic show a close relationship to the vaccine strain A5 Allier 60 but were probably derived from another not yet identified vaccine strain from Spain. Only two minor outbreaks in the Federal Republic of Germany, A Aachen in 1976 and O Wuppertal in 1982, did not correspond to the classical European strains but were obviously introduced from outside. We suggest that nucleotide sequence analysis should be used as a standard method of diagnosis, because when compared with other techniques it more clearly reveals the origin and course of epizootics and offers the possibility of preventing further outbreaks.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3033288      PMCID: PMC254144          DOI: 10.1128/JVI.61.5.1621-1629.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

1.  Serological differentiation of foot-and-mouth disease virus strains in relation to selection of suitable vaccine viruses.

Authors:  M M Rweyemamu; T W Pay; M J Parker
Journal:  Dev Biol Stand       Date:  1976

2.  [Studies on the typing of a foot-and-mouth disease strain (type A)].

Authors:  H O Böhm; O R Kaaden
Journal:  Berl Munch Tierarztl Wochenschr       Date:  1978-07-01       Impact factor: 0.328

3.  [Antigenic and immunological relationships between the A sub-types of the foot-and-mouth disease virus. 1. After inoculation of guinea-pigs with active virus].

Authors:  G Wittmann
Journal:  Zentralbl Veterinarmed B       Date:  1966-06

4.  Computer programs for the analysis and the management of DNA sequences.

Authors:  G Osterburg; K H Glatting; R Sommer
Journal:  Nucleic Acids Res       Date:  1982-01-11       Impact factor: 16.971

5.  Biochemical identification of viruses causing the 1981 outbreaks of foot and mouth disease in the UK.

Authors:  A M King; B O Underwood; D McCahon; J W Newman; F Brown
Journal:  Nature       Date:  1981-10-08       Impact factor: 49.962

6.  Sequencing end-labeled DNA with base-specific chemical cleavages.

Authors:  A M Maxam; W Gilbert
Journal:  Methods Enzymol       Date:  1980       Impact factor: 1.600

7.  Location and characterization of the antigenic portion of the FMDV immunizing protein.

Authors:  K Strohmaier; R Franze; K H Adam
Journal:  J Gen Virol       Date:  1982-04       Impact factor: 3.891

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Optimized conditions for solid-phase sequencing: simultaneous chemical cleavage of a series of long DNA fragments immobilized on CCS anion-exchange paper.

Authors:  A Rosenthal; R Jung; H D Hunger
Journal:  Gene       Date:  1986       Impact factor: 3.688

10.  Nucleotide sequence and corresponding amino acid sequence of the gene for the major antigen of foot and mouth disease virus.

Authors:  C Kurz; S Forss; H Küpper; K Strohmaier; H Schaller
Journal:  Nucleic Acids Res       Date:  1981-04-24       Impact factor: 16.971

View more
  75 in total

1.  Molecular epidemiology of serotype O foot-and-mouth disease virus with emphasis on West and South Africa.

Authors:  O Sangare; A D Bastos; O Marquardt; E H Venter; W Vosloo; G R Thomson
Journal:  Virus Genes       Date:  2001-06       Impact factor: 2.332

2.  Foot-and-mouth disease virus O1Lombardy is biochemically related to O2 isolates.

Authors:  O Krebs; H G Berger; W Niedbalski; O Marquardt
Journal:  Virus Genes       Date:  1991-07       Impact factor: 2.332

3.  Identification of neutralizing antigenic sites on VP1 and VP2 of type A5 foot-and-mouth disease virus, defined by neutralization-resistant variants.

Authors:  J C Saiz; M J Gonzalez; M V Borca; F Sobrino; D M Moore
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

4.  Nucleotide sequence of the P1 region of foot-and-mouth disease virus strain O1 Caseros.

Authors:  C Tami; G Kaplan; M E Piccone; E L Palma
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

5.  Plasmid DNA encoding replicating foot-and-mouth disease virus genomes induces antiviral immune responses in swine.

Authors:  G Ward; E Rieder; P W Mason
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

6.  High-affinity antibody induced by immunization with a synthetic peptide is associated with protection of cattle against foot-and-mouth disease.

Authors:  M W Steward; C M Stanley; R Dimarchi; G Mulcahy; T R Doel
Journal:  Immunology       Date:  1991-01       Impact factor: 7.397

7.  Antigenic heterogeneity of a foot-and-mouth disease virus serotype in the field is mediated by very limited sequence variation at several antigenic sites.

Authors:  M G Mateu; J Hernández; M A Martínez; D Feigelstock; S Lea; J J Pérez; E Giralt; D Stuart; E L Palma; E Domingo
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

8.  Emergence of a new strain of type O foot-and-mouth disease virus: its phylogenetic and evolutionary relationship with the PanAsia pandemic strain.

Authors:  Divakar Hemadri; Chakradhar Tosh; Aniket Sanyal; Ramamurthy Venkataramanan
Journal:  Virus Genes       Date:  2002       Impact factor: 2.332

9.  Inactivation of human cytomegalovirus by sodium periodate oxidation.

Authors:  F Geoffroy; G Ogier; J Chantepie; G Quash
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

10.  Engineering viable foot-and-mouth disease viruses with increased thermostability as a step in the development of improved vaccines.

Authors:  Roberto Mateo; Eva Luna; Verónica Rincón; Mauricio G Mateu
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.